Diagnostic Medical Systems S.A. (FRA:DMS1)

Germany · Delayed Price · Currency is EUR

0.9200

-0.0220 (-2.34%)

Last updated: Aug 27, 2026, 8:06 AM CET

-39.67% (1Y)

Market Cap	26.30M -8.2%
Revenue (ttm)	52.86M +8.2%
Net Income	-167.00K
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	29.23
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.9200
Previous Close	0.9420
Day's Range	0.9200 - 0.9200
52-Week Range	0.9200 - 1.5900
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 14, 2026

About FRA:DMS1

Diagnostic Medical Systems S.A. designs, develops, manufactures, and sells medical imaging systems in France. The company offers ADAM, a software suite for imaging experts; R and F solutions, including Platinum Neo, Platinum Flex, and Optima; bone densitometers, including Stratos and Medix Series; MISTRAL, a manual chest and bone solution; and Camargue series which offers motorized radiographic systems to perform all types of bone and chest exams, including full spine and long leg exams. It also provides mobiles under the !M1, ONYX, Rafale/Rafa... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus

Founded 1979

Employees 146

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol DMS1

Financial Performance

In 2025, FRA:DMS1's revenue was 52.86 million, an increase of 8.19% compared to the previous year's 48.86 million. Losses were -167,000, -94.20% less than in 2024.

Financial Statements